340B Drug Pricing Program Reporting

Beginning in 2024, Minnesota health care entities that participate as “covered entities” in the federal 340B Drug Pricing Program are required to annually report data related to their 340B prescription drug purchases and payments to the Minnesota Department of Health (MDH). MDH submits its findings in annual reports to the Legislature on the reported data. 

This website serves as a means to monitor progress, access resources, ask questions, and sign up for email updates for news and notifications. 

NEW: MDH released findings from the nation's first state transparency initiative on the federal 340B Drug Pricing Program. The report can be accessed on the 340B Reports webpage. 

Report Resources

Reporting entities preparing to submit a report are encouraged to access the online reporting system to register at the Rx Data Portal. Data submitters may visit the Data Reporting Help page for more resources. 

Additional reporting resources:

• Form and Manner for 340B Covered Entities (PDF)—March 2024
• Frequently Asked Questions (PDF)—March 2024
• Rx Data Portal
• Tutorial: Online Portal for 340B Reporting (YouTube)

For other instructional videos and user guides for the online reporting systems at the Rx Data Portal, please view MDH's Rx Data Reporting Help page. 

Upcoming Implementation Steps 

• Winter 2024: MDH releases revised reporting guidance resulting from 2024 legislative changes for public comment
• Early 2025: MDH releases finalized reporting guidance, reporting resources, and updated reporting functionality on the Rx Data Portal for 2025 reporting
• April 1, 2025: Covered entities’ reports are due to MDH